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Ciliopathy is a general term applied to diseases that origi-
nate from ciliary dysfunction, which often coincide with
renal cyst development. Any syndrome displaying renal
cysts, such as folliculin (FLCN) in Birt-Hogg-Dube (BHD)
syndrome, might therefore be suspected as a novel ciliopa-
thy. Indeed, FLCN localizes to the primary cilium. To
study ciliopathies in detail, we set up a renal 3D culture
system using IMCD3 cells that physiologically mimick
polarized renal tubuli. SiFlcn was essayed in this system,
identifying several affected processes; 1) Reduction of cilia-
tion in vitro and in vivo. 2) Increase in cell volume. 3)
Increase of mis-oriented cell divisions. These results sug-
gest Flcn functions in cilia stability/ciliogenesis and planar
cell polarity (PCP) regulation. PCP signaling is a form of
non-canonical Wnt signaling subjected to ciliary regulation
Accordingly, whereas b-catenin is normally present in the
axoneme, this is never observed upon Flcn depletion and
Wnt signaling appears increased as downstream effector
Axin2 is stabilized. This suggests a switch from PCP to
canonical signaling. Notably, upon ectopic GFP-FLCN
expression, but not the non-functional allele p.L508R, cilia
become stabilized, accompanied by an accumulation of
both GFP-FLCN and b-catenin in the cilium. The second
most common mutant FLCN allele is p.T463X; forced
read-through with pharmaceutical agent PTC124, targeting
nonsense-mediated decay, was tested and showed a robust
response as protein expression appears fully restored. We
suggest that BHD regulates ciliary function in a 3D polar-
ized cell assay, and PTC124 might be a simple therapy for
the second most frequent allele in BHD carriers.
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